CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
REVENUES:
Net product sales	$ 6,209,625	$ 7,247,881	$ 18,145,864	$ 19,400,515
R&D, milestone and grant revenue	658,665	57,946	1,654,788	1,133,850
License and Maintenance Revenue	19,084	8,482	34,017	15,613
TOTAL REVENUES	6,887,374	7,314,309	19,834,669	20,549,978
Cost of product sales	3,976,840	4,663,919	11,218,385	12,644,427
GROSS MARGIN	2,910,534	2,650,390	8,616,284	7,905,551
OPERATING EXPENSES:
Research and development expenses	1,570,044	972,439	4,911,587	3,438,714
Selling, general and administrative expenses	1,919,551	1,940,424	6,057,221	5,344,914
TOTAL OPERATING EXPENSES	3,489,595	2,912,863	10,968,808	8,783,628
(LOSS) FROM OPERATIONS	(579,061)	(262,473)	(2,352,524)	(878,077)
OTHER INCOME:
(Loss) gain on sale of fixed asset	0	0	0	(5,707)
Interest income	353	1,136	1,844	4,527
Interest expense	(749)	0	(749)	0
TOTAL OTHER INCOME (EXPENSES)	(396)	1,136	1,095	(1,180)
(LOSS) BEFORE INCOME TAXES	(579,457)	(261,337)	(2,351,429)	(879,257)
Income tax (benefit)	(142,300)	9,284	(603,370)	(237,916)
NET (LOSS)	$ (437,157)	$ (270,621)	$ (1,748,059)	$ (641,341)
Basic (loss) per share	$ (0.05)	$ (0.03)	$ (0.18)	$ (0.07)
Diluted (loss) per share	$ (0.05)	$ (0.03)	$ (0.18)	$ (0.07)
Weighted average number of shares outstanding, basic (in shares)	9,628,248	9,611,139	9,625,282	9,503,084
Weighted average number of shares outstanding, diluted (in shares)	9,628,248	9,611,139	9,625,282	9,503,084